Aspen Pharmacare Holdings Future Growth
Future criteria checks 3/6
Aspen Pharmacare Holdings's revenue is forecast to decline at 1.2% per annum while its annual earnings are expected to grow at 56.2% per year. EPS is expected to grow by 59.3% per annum. Return on equity is forecast to be 6% in 3 years.
Key information
56.2%
Earnings growth rate
59.26%
EPS growth rate
| Pharmaceuticals earnings growth | 13.5% |
| Revenue growth rate | -1.2% |
| Future return on equity | 5.96% |
| Analyst coverage | Low |
| Last updated | 15 Jun 2026 |
Recent future growth updates
Recent updates
Analysis Article • Jan 10
Aspen Pharmacare Holdings Limited's (JSE:APN) 29% Share Price Surge Not Quite Adding Up
Aspen Pharmacare Holdings Limited ( JSE:APN ) shareholders would be excited to see that the share price has had a great...Analysis Article • Nov 28
We Discuss Why Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation May Be Closely Reviewed
Key Insights Aspen Pharmacare Holdings will host its Annual General Meeting on 4th of December CEO Stephen Saad's total...Analysis Article • Nov 18
Investors Aren't Buying Aspen Pharmacare Holdings Limited's (JSE:APN) Revenues
Aspen Pharmacare Holdings Limited's ( JSE:APN ) price-to-sales (or "P/S") ratio of 1x may look like a pretty appealing...
Narrative Update • Sep 17
Commercial Pharma And GLP-1 Expansion Will Empower Future Progress
Aspen Pharmacare Holdings' consensus price target has decreased to ZAR120.60, reflecting concerns over a sharply higher future P/E and a substantial decline in net profit margin. What's in the News Aspen Pharmacare Holdings Limited announced an annual dividend of ZAR 2.1100 per share.Analysis Article • Sep 06
Aspen Pharmacare Holdings' (JSE:APN) Dividend Is Being Reduced To ZAR2.11
Aspen Pharmacare Holdings Limited ( JSE:APN ) has announced that on 6th of October, it will be paying a dividend...Analysis Article • Aug 04
Aspen Pharmacare Holdings Limited's (JSE:APN) Share Price Could Signal Some Risk
When close to half the companies in South Africa have price-to-earnings ratios (or "P/E's") below 8x, you may consider...Analysis Article • Apr 24
Aspen Pharmacare Holdings Limited (JSE:APN) Shares May Have Slumped 35% But Getting In Cheap Is Still Unlikely
The Aspen Pharmacare Holdings Limited ( JSE:APN ) share price has fared very poorly over the last month, falling by a...
New Narrative • Apr 06
Commercial Pharma And GLP-1 Expansion Will Empower Future Progress
Steady commercial pharma growth through strategic market focus in China and Russia enhances revenue stability.Analysis Article • Mar 06
Does Aspen Pharmacare Holdings (JSE:APN) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Nov 29
We Think Shareholders May Want To Consider A Review Of Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Package
Key Insights Aspen Pharmacare Holdings' Annual General Meeting to take place on 5th of December Salary of R9.62m is...Analysis Article • Nov 09
Aspen Pharmacare Holdings Limited (JSE:APN) Not Lagging Market On Growth Or Pricing
When close to half the companies in South Africa have price-to-earnings ratios (or "P/E's") below 10x, you may consider...Analysis Article • Oct 10
Aspen Pharmacare Holdings' (JSE:APN) Conservative Accounting Might Explain Soft Earnings
The market for Aspen Pharmacare Holdings Limited's ( JSE:APN ) shares didn't move much after it posted weak earnings...Analysis Article • Oct 01
Here's Why Aspen Pharmacare Holdings (JSE:APN) Has A Meaningful Debt Burden
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Sep 10
Aspen Pharmacare Holdings (JSE:APN) Has Announced That It Will Be Increasing Its Dividend To ZAR3.59
Aspen Pharmacare Holdings Limited ( JSE:APN ) has announced that it will be increasing its dividend from last year's...Analysis Article • May 08
We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Mar 05
Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable
When close to half the companies in South Africa have price-to-earnings ratios (or "P/E's") below 8x, you may consider...Analysis Article • Dec 22
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Dec 01
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Key Insights Aspen Pharmacare Holdings to hold its Annual General Meeting on 7th of December Salary of R9.17m is part...Analysis Article • Mar 31
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Jan 11
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analysis Article • Oct 22
These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Oct 06
We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analysis Article • Sep 21
Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's
Aspen Pharmacare Holdings Limited's ( JSE:APN ) dividend will be increasing from last year's payment of the same period...Analysis Article • Sep 08
Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially
Market forces rained on the parade of Aspen Pharmacare Holdings Limited ( JSE:APN ) shareholders today, when the...Analysis Article • Sep 07
Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26
Aspen Pharmacare Holdings Limited ( JSE:APN ) has announced that it will be increasing its dividend from last year's...Analysis Article • Jun 15
Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analysis Article • Apr 02
Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Mar 16
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...Analysis Article • Mar 02
An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued
In this article we are going to estimate the intrinsic value of Aspen Pharmacare Holdings Limited ( JSE:APN ) by taking...Analysis Article • Dec 23
Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • Dec 02
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Performance at Aspen Pharmacare Holdings Limited ( JSE:APN ) has been rather uninspiring recently and shareholders may...Analysis Article • Oct 11
We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative
The subdued stock price reaction suggests that Aspen Pharmacare Holdings Limited's ( JSE:APN ) strong earnings didn't...Analysis Article • Sep 30
After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar
Aspen Pharmacare Holdings Limited ( JSE:APN ) shares have continued their recent momentum with a 42% gain in the last...Analysis Article • Sep 30
Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump
Aspen Pharmacare Holdings Limited ( JSE:APN ) shares have continued their recent momentum with a 42% gain in the last...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2028 | 41,017 | 5,487 | 4,746 | 7,834 | 4 |
| 6/30/2027 | 38,766 | 4,915 | 3,344 | 6,864 | 4 |
| 6/30/2026 | 39,763 | 4,456 | 2,874 | 7,569 | 4 |
| 12/31/2025 | 42,592 | -1,806 | 2,953 | 6,931 | N/A |
| 9/30/2025 | 42,978 | -1,444 | 1,543 | 6,045 | N/A |
| 6/30/2025 | 43,363 | -1,083 | 132 | 5,159 | N/A |
| 3/31/2025 | 40,333 | 899 | 190 | 5,366 | N/A |
| 12/31/2024 | 41,414 | 3,679 | 247 | 5,572 | N/A |
| 9/30/2024 | 43,060 | 4,042 | 470 | 5,899 | N/A |
| 6/30/2024 | 44,706 | 4,404 | 692 | 6,225 | N/A |
| 3/31/2024 | 43,703 | 4,636 | 1,023 | 6,248 | N/A |
| 12/31/2023 | 42,700 | 4,868 | 1,354 | 6,271 | N/A |
| 9/30/2023 | 41,705 | 5,048 | 1,849 | 5,896 | N/A |
| 6/30/2023 | 40,709 | 5,228 | 2,343 | 5,520 | N/A |
| 3/31/2023 | 39,542 | 5,515 | 2,545 | 5,420 | N/A |
| 12/31/2022 | 38,375 | 5,802 | 2,747 | 5,320 | N/A |
| 9/30/2022 | 38,491 | 6,145 | 2,875 | 5,347 | N/A |
| 6/30/2022 | 38,606 | 6,488 | 3,002 | 5,374 | N/A |
| 3/31/2022 | 38,560 | 6,185 | 3,826 | 6,110 | N/A |
| 12/31/2021 | 38,514 | 5,881 | 4,649 | 6,846 | N/A |
| 9/30/2021 | 38,140 | 5,340 | 4,209 | 6,836 | N/A |
| 6/30/2021 | 37,766 | 4,798 | 3,769 | 6,825 | N/A |
| 3/31/2021 | 35,760 | 3,954 | 4,119 | 7,115 | N/A |
| 12/31/2020 | 36,308 | 3,782 | 4,468 | 7,405 | N/A |
| 9/30/2020 | 34,984 | 3,581 | 5,141 | 7,833 | N/A |
| 6/30/2020 | 33,659 | 3,380 | 5,814 | 8,260 | N/A |
| 3/31/2020 | 39,927 | 3,272 | 4,508 | 7,573 | N/A |
| 12/31/2019 | 33,620 | 870 | 3,202 | 6,886 | N/A |
| 9/30/2019 | 34,567 | 1,275 | N/A | 6,444 | N/A |
| 6/30/2019 | 35,514 | 1,679 | N/A | 6,002 | N/A |
| 3/31/2019 | 36,880 | 3,350 | N/A | 5,864 | N/A |
| 12/31/2018 | 36,683 | 4,890 | N/A | 5,726 | N/A |
| 9/30/2018 | 37,499 | 5,256 | N/A | 6,372 | N/A |
| 6/30/2018 | 38,314 | 5,621 | N/A | 7,017 | N/A |
| 3/31/2018 | 39,618 | 5,682 | N/A | 6,653 | N/A |
| 12/31/2017 | 40,922 | 5,743 | N/A | 6,289 | N/A |
| 9/30/2017 | 41,068 | 5,436 | N/A | 6,388 | N/A |
| 6/30/2017 | 41,213 | 5,128 | N/A | 6,487 | N/A |
| 3/31/2017 | 39,557 | 4,414 | N/A | 5,694 | N/A |
| 12/31/2016 | 37,900 | 3,700 | N/A | 4,900 | N/A |
| 9/30/2016 | 36,750 | 4,000 | N/A | 4,050 | N/A |
| 6/30/2016 | 35,600 | 4,300 | N/A | 3,200 | N/A |
| 3/31/2016 | 35,583 | 5,220 | N/A | 3,406 | N/A |
| 12/31/2015 | 35,567 | 6,140 | N/A | 3,613 | N/A |
| 9/30/2015 | 35,833 | 5,670 | N/A | 4,206 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: APN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (9.8%).
Earnings vs Market: APN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: APN is expected to become profitable in the next 3 years.
Revenue vs Market: APN's revenue is expected to decline over the next 3 years (-1.2% per year).
High Growth Revenue: APN's revenue is forecast to decline over the next 3 years (-1.2% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: APN's Return on Equity is forecast to be low in 3 years time (6%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/01 16:57 |
| End of Day Share Price | 2026/07/01 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aspen Pharmacare Holdings Limited is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rendani Magalela | Absa Bank Limited |
| Andre Bekker | Arqaam Capital Research Offshore S.A.L. |
| Boitshepo Seruwe | Avior Capital Markets |